{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-021351","form_type":"8-K","ticker":"NPHC","cik":"0001119643","company_name":"NUTRA PHARMA CORP","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.025990+00:00","generated_at":"2026-06-24T03:42:16.296950+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Nutra Pharma appoints Marcum LLP as new independent auditor after Rotenberg merger","bullets":["Rotenberg, prior auditor, combined with Marcum LLP in Feb 2022; continued as subsidiary through Q1 2022.","On July 28, 2022, Audit Committee engaged Marcum LLP as auditor for FY 2022; Rotenberg resigned.","Rotenberg's 2021 audit report included going concern paragraph due to lack of cash, losses, capital needs.","No disagreements or reportable events with Rotenberg during the two most recent fiscal years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-021351","json":"https://secwatch.observer/filing/0001493152-22-021351.json","markdown":"https://secwatch.observer/filing/0001493152-22-021351.md","text":"https://secwatch.observer/filing/0001493152-22-021351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1119643/000149315222021351/0001493152-22-021351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1119643/000149315222021351/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:42:16.296950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}